Newborn screening testing services for brian allgood community hospital (BAACH)/121ST combat support hospital (CSH), usameddac-korea - base period (29 SEP 2019 - 28 SEP 2020)
Ended Awarded Last action
- Contract number
- W81K0219F0292
- Awardee
-
Revvity Omics Inc. UEI LDJULX8K6M85 Part of Revvity Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $33,880
Award facts
- Opportunity
-
- W81K0219Q0218 Solicitation number
- Newborn Screening Testing Services for U. S. Army Medical Department Activity, Korea Award Notice · Posted Aug 12, 2019
- Contract value 100% obligated
- $33,880.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$9,240 | |
| Original award | $43,120 |
About this award
The Department of the Army Medical Command awarded a firm fixed price delivery order valued at thirty-three thousand eight hundred eighty dollars to Perkinelmer Genetics, Inc. to provide newborn screening testing services for Brian Allgood Community Hospital and the one hundred twenty-first Combat Support Hospital in Korea under the base period from September twenty-nine, two thousand nineteen through September twenty-eight, two thousand twenty. The order was issued off an unidentified medical services vehicle and had no set-aside designation. Perkinelmer Genetics will perform the work with support from its parent company Revvity Inc.'s Medical Imaging division. The testing will help the Army medical treatment facilities screen newborns for conditions to support service members and their families in Korea.
Quick answers
Who was awarded contract W81K0219F0292?
W81K0219F0292 was awarded to Revvity Omics Inc. by Medical Command (Department of the Army) on September 29, 2019.
How much is contract W81K0219F0292 worth?
The government has obligated $33,880 on W81K0219F0292.
Is contract W81K0219F0292 an order under another contract?
Yes. W81K0219F0292 is a delivery order under W81K0219D0011, an indefinite delivery contract.
Was contract W81K0219F0292 competed?
The extent of competition for W81K0219F0292 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award